After a stem cell transplant for myeloma, being MRD positive (still having detectable myeloma cells) is actually quite common. Even when treatment goes well and a person achieves what's called a "complete response," some myeloma cells can still remain — they may have become resistant to treatment or simply escaped its Show Full Answer
After a stem cell transplant for myeloma, being MRD positive (still having detectable myeloma cells) is actually quite common. Even when treatment goes well and a person achieves what's called a "complete response," some myeloma cells can still remain — they may have become resistant to treatment or simply escaped its effects.
MRD negativity (no detectable cancer cells in 1 million bone marrow cells tested) is considered a very positive outcome, but not everyone reaches this after transplant. Achieving MRD negativity is associated with longer remission periods. Here's what's important to understand about MRD results after transplant:
- MRD positive doesn't automatically mean treatment has failed — it just means some cells are still detectable
- MRD negative doesn't guarantee the myeloma won't return
- Doctors monitor MRD over time to track trends, not just a single result
- There are currently no firm guidelines on exactly how MRD results should change treatment decisions
The good news is that MRD testing is becoming more refined, and doctors are getting better at using this information to guide ongoing care. Always discuss your specific results with your care team, as context matters a lot.
July 9
Join
Your Privacy Choices
